Sichuan Goldstone Asia Pharmaceutical Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 231 264 239 173 117 162 704 971 1,006 777 1,054 1,243 1,209 1,102
Przychód Δ r/r 0.0% 14.2% -9.7% -27.6% -32.2% 38.7% 333.5% 37.9% 3.6% -22.7% 35.5% 17.9% -2.7% -8.8%
Marża brutto 41.7% 39.6% 37.2% 39.5% 39.3% 34.6% 64.0% 65.9% 64.5% 53.9% 56.7% 61.3% 61.3% 57.4%
EBIT (mln) 63 66 53 37 21 24 148 189 161 -668 89 292 178 130
EBIT Δ r/r 0.0% 5.2% -18.8% -31.4% -43.3% 15.5% 518.2% 27.7% -15.2% -516.0% -113.3% 228.1% -39.1% -26.7%
EBIT (%) 27.0% 24.9% 22.4% 21.2% 17.7% 14.8% 21.1% 19.5% 16.0% -85.9% 8.4% 23.5% 14.7% 11.8%
Koszty finansowe (mln) 0 0 0 0 2 1 10 2 1 0 0 0 1 1
EBITDA (mln) 60 69 59 41 21 25 208 274 268 96 214 375 272 229
EBITDA(%) 26.1% 26.1% 24.9% 23.6% 17.5% 15.3% 29.5% 28.2% 26.6% 12.4% 20.4% 30.1% 22.5% 20.7%
Podatek (mln) 9 9 8 5 3 4 35 36 34 19 27 77 56 34
Zysk Netto (mln) 54 57 49 32 23 26 116 149 120 -688 66 219 126 92
Zysk netto Δ r/r 0.0% 5.4% -14.0% -34.3% -27.2% 9.2% 353.9% 28.7% -19.3% -671.5% -109.7% 229.1% -42.3% -27.3%
Zysk netto (%) 23.3% 21.5% 20.5% 18.6% 20.0% 15.7% 16.5% 15.4% 12.0% -88.5% 6.3% 17.6% 10.4% 8.3%
EPS 0.29 0.31 0.27 0.18 0.1 0.11 0.37 0.37 0.3 -1.71 0.17 0.54 0.31 0.23
EPS (rozwodnione) 0.29 0.31 0.27 0.18 0.1 0.11 0.37 0.37 0.3 -1.71 0.17 0.54 0.31 0.23
Ilośc akcji (mln) 183 184 183 183 224 242 314 402 402 402 402 402 407 399
Ważona ilośc akcji (mln) 183 184 183 183 224 242 314 403 402 402 402 402 407 399
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY